- Home
- SSKN vs ICU Comparison
SSKN vs ICU Comparison
Compare SSKN & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSKN
- ICU
- Stock Information
- Founded
- SSKN 1989
- ICU 2018
- Country
- SSKN United States
- ICU United States
- Employees
- SSKN N/A
- ICU N/A
- Industry
- SSKN Medical/Dental Instruments
- ICU Biotechnology: Pharmaceutical Preparations
- Sector
- SSKN Health Care
- ICU Health Care
- Exchange
- SSKN Nasdaq
- ICU Nasdaq
- Market Cap
- SSKN 9.7M
- ICU 10.4M
- IPO Year
- SSKN 2005
- ICU N/A
- Fundamental
- Price
- SSKN $2.36
- ICU $0.57
- Analyst Decision
- SSKN Strong Buy
- ICU
- Analyst Count
- SSKN 1
- ICU 0
- Target Price
- SSKN $6.00
- ICU N/A
- AVG Volume (30 Days)
- SSKN 18.6K
- ICU 19.3M
- Earning Date
- SSKN 08-13-2025
- ICU 08-12-2025
- Dividend Yield
- SSKN N/A
- ICU N/A
- EPS Growth
- SSKN N/A
- ICU N/A
- EPS
- SSKN N/A
- ICU N/A
- Revenue
- SSKN $33,620,000.00
- ICU $428,000.00
- Revenue This Year
- SSKN $3.31
- ICU $754.07
- Revenue Next Year
- SSKN $9.67
- ICU $100.09
- P/E Ratio
- SSKN N/A
- ICU N/A
- Revenue Growth
- SSKN 3.30
- ICU N/A
- 52 Week Low
- SSKN $2.10
- ICU $0.31
- 52 Week High
- SSKN $3.80
- ICU $9.56
- Technical
- Relative Strength Index (RSI)
- SSKN 48.71
- ICU 38.28
- Support Level
- SSKN $2.34
- ICU $0.51
- Resistance Level
- SSKN $2.53
- ICU $0.91
- Average True Range (ATR)
- SSKN 0.21
- ICU 0.13
- MACD
- SSKN 0.01
- ICU 0.03
- Stochastic Oscillator
- SSKN 23.19
- ICU 32.90
About SSKN Strata Skin Sciences Inc.
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.
About ICU SeaStar Medical Holding Corporation
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.